Muller, M.; Godet, J.; Delabranche, X.; Sattler, L.; Millard, D.; Marzak, H.; Mertes, P.M.; Steib, A.; Grunebaum, L.; Jesel, L.;
et al. Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters. J. Clin. Med. 2023, 12, 2236.
https://doi.org/10.3390/jcm12062236
AMA Style
Muller M, Godet J, Delabranche X, Sattler L, Millard D, Marzak H, Mertes PM, Steib A, Grunebaum L, Jesel L,
et al. Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters. Journal of Clinical Medicine. 2023; 12(6):2236.
https://doi.org/10.3390/jcm12062236
Chicago/Turabian Style
Muller, Marie, Julien Godet, Xavier Delabranche, Laurent Sattler, David Millard, Halim Marzak, Paul Michel Mertes, Annick Steib, Lelia Grunebaum, Laurence Jesel,
and et al. 2023. "Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters" Journal of Clinical Medicine 12, no. 6: 2236.
https://doi.org/10.3390/jcm12062236
APA Style
Muller, M., Godet, J., Delabranche, X., Sattler, L., Millard, D., Marzak, H., Mertes, P. M., Steib, A., Grunebaum, L., Jesel, L., & Tacquard, C. A.
(2023). Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters. Journal of Clinical Medicine, 12(6), 2236.
https://doi.org/10.3390/jcm12062236
